Stergiou, N ; Wuensche, T. E ; Schreurs, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027647/.  , 2023

D. G. J. Linders ; M. M. Deken ; M. A. van Dam...
https://www.mdpi.com/2072-6694/15/20/4980.  , 2023

Adams, H ; van de Garde, E M W ; Vugts, D J...
1619-7070.  , 2023

Adams, H ; van de Garde, E. M. W ; Vugts, D. J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199842/.  , 2023

Stergiou, N ; Wünsche, E. T ; Mes, I...
Stergiou , N , Wünsche , E T , Mes , I , Schreurs , M , Verlaan , M , Kooijman , E J M , Windhorst , A D , Dongen , G A M S , Helboe , L , Vergo , S , Christensen , S , Asuni , A , Jensen , A , Bang-Andersen , B , Vugts , D J & Beaino , W 2021 , ' Corrigendum to "SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake" [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31] (Nuclear Medicine and Biology (2021) 96–97(S) (S1–S114), (S0969805121X00042)) ' , Nuclear Medicine and Biology . https://doi.org/10.1016/j.nucmedbio.2021.05.006.  , 2021

Aftimos P ; Rolfo C ; Rottey S...
info:eu-repo/semantics/altIdentifier/pmid/34200749.  , 2021

Aime S ; Al-Qahtani M ; Behe M...
info:eu-repo/semantics/altIdentifier/pmid/33738618.  , 2021

van Helden, E. J ; Elias, S. G ; Gerritse, S. L...
van Helden , E J , Elias , S G , Gerritse , S L , van Es , S C , Boon , E , Huisman , M C , van Grieken , N C T , Dekker , H , van Dongen , G A M S , Vugts , D J , Boellaard , R , van Herpen , C M L , de Vries , E G E , Oyen , W J G , Brouwers , A H , Verheul , H M W , Hoekstra , O S & der Houven van Oordt , C W M V 2020 , ' Correction to : [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 47, 4, (849-859), 10.1007/s00259-019-04555-6) ' , European Journal of Nuclear Medicine and Molecular Imaging , vol. 47 , no. 10 , pp. 2481 . https://doi.org/10.1007/s00259-020-04908-6.  , 2020

van Helden, E. J ; Elias, S. G ; Gerritse, S. L...
https://research.rug.nl/en/publications/da94b5d8-8ca8-4c52-9158-c5c276ad65c6.  , 2020

van Helden, E. J ; Elias, S. G ; Gerritse, S. L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645532/.  , 2020

van Helden, E. J ; Elias, S. G ; Gerritse, S. L...
van Helden , E J , Elias , S G , Gerritse , S L , van Es , S C , Boon , E , Huisman , M C , van Grieken , N C T , Dekker , H , van Dongen , G A M S , Vugts , D J , Boellaard , R , van Herpen , C M L , de Vries , E G E , Oyen , W J G , Brouwers , A H , Verheul , H M W , Hoekstra , O S & Menke-van der Houven van Oordt , C W 2020 , ' [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer ' , European Journal of Nuclear Medicine and Molecular Imaging , vol. 47 , no. 4 , pp. 849-859 . https://doi.org/10.1007/s00259-019-04555-6.  , 2020

van Helden, E. J ; Elias, S. G ; Gerritse, S. L...
https://research.rug.nl/en/publications/22be926c-b15c-4a15-962e-99fa9cc8afa1.  , 2020

van Helden, E J ; Elias, S G ; Gerritse, S L...
1619-7070.  , 2020

Patruno I ; Thomson D ; Mody N...
doi:10.5281/zenodo.3952481.  , 2020

Ankersmit, M ; Hoekstra, O.S ; van Lingen, A...
Ankersmit , M , Hoekstra , O S , van Lingen , A , Bloemena , E , Jacobs , M A J M , Vugts , D J , Bonjer , H J , van Dongen , G A M S & Meijerink , W J H J 2019 , ' Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer ' , European Journal of Nuclear Medicine and Molecular Imaging , vol. 46 , no. 7 , pp. 1495-1505 . https://doi.org/10.1007/s00259-019-04284-w.  , 2019